Expertise in
14
conditions

Dr. Sandra M. Johnson

Fort Smith, AR
Expertise in
14
conditions
Specialties:Dermatology
Accepting New Patients
Expertise in
14
conditions
OverviewInsuranceLocationsClinical Research

Overview

Sandra Johnson is a Dermatologist in Fort Smith, Arkansas. Dr. Johnson is highly rated in 14 conditions, according to our data. Her top areas of expertise are Acne, Rosacea, Plaque Psoriasis, and Actinic Keratosis. Dr. Johnson is currently accepting new patients.

Her clinical research consists of co-authoring 24 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Dermatology
Licenses
Dermatology in AR
Languages Spoken
English
Gender
Female

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Blue Cross Blue Shield
  •  HMO Partners
  •  UnitedHealthcare
  •  Oscar
  •  Humana

Locations

JOHNSON DERMATOLOGY CLINIC PLLC
5921 Riley Park Dr, Fort Smith, AR 72916
479-649-3376

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

9 Clinical Trials

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Operationally Seamless, Adaptive Phase 2/3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Severe or Very Severe Alopecia Areata
Enrollment Status: Active_not_recruiting
Publish Date: January 27, 2025
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 2/Phase 3
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
A Long-term Study to Assess the Safety and Efficacy of Lebrikizumab in Patients With Moderate-to-Severe Atopic Dermatitis (ADjoin)
Enrollment Status: Active_not_recruiting
Publish Date: January 23, 2025
Intervention Type: Biological
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Pragmatic Trial of Home Versus Office Based Narrow Band Ultraviolet B Phototherapy for the Treatment of Psoriasis
A Pragmatic Trial of Home Versus Office Based Narrow Band Ultraviolet B Phototherapy for the Treatment of Psoriasis
Enrollment Status: Completed
Publish Date: September 19, 2024
Intervention Type: Device
Study Phase: Not Applicable
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
A Randomized, Double-blind, Placebo Controlled Trial to Evaluate the Efficacy and Safety of Lebrikizumab in Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: November 30, 2022
Intervention Type: Biological, Other
Study Drug: Lebrikizumab
Study Phase: Phase 3
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Open-Label, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Terminated
Publish Date: November 08, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients With Moderate to Severe Atopic Dermatitis
Enrollment Status: Completed
Publish Date: September 09, 2022
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Enrollment Status: Completed
Publish Date: November 20, 2020
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
A 24-Week Multicenter, Randomized, Blinded, Parallel-Group Study Comparing the Efficacy and Safety of Ixekizumab to Guselkumab in Patients With Moderate-to-Severe Plaque Psoriasis
Enrollment Status: Completed
Publish Date: July 28, 2020
Intervention Type: Drug
Study Phase: Phase 4
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Varying Regimens of CANDIN for Treatment of Common Warts (Verruca Vulgaris)
Enrollment Status: Completed
Publish Date: June 04, 2019
Intervention Type: Other, Biological
Study Phase: Phase 2
View 8 Less Clinical Trials

27 Total Publications

Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial.
Home- vs Office-Based Narrowband UV-B Phototherapy for Patients With Psoriasis: The LITE Randomized Clinical Trial.
Journal: JAMA dermatology
Published: September 25, 2024
Similar Doctors
Expertise in
19
conditions
Dr. George L. Lewis
Dermatology
Expertise in
19
conditions
Dr. George L. Lewis
Dermatology

The Dermatology Center PLLC

7900 Dallas Street,, 
Fort Smith, AR 
 (5.8 mi)
479-242-6647
Languages Spoken:
English
See accepted insurances
Accepting New Patients

George Lewis is a Dermatologist in Fort Smith, Arkansas. Dr. Lewis is highly rated in 19 conditions, according to our data. His top areas of expertise are Aseptic and Alopecic Nodules of Scalp (AANS), Basal Cell Skin Cancer, Squamous Cell Skin Carcinoma, and Actinic Keratosis. Dr. Lewis is currently accepting new patients.

Expertise in
26
conditions
Dr. Phillip C. Stites
Dermatology
Expertise in
26
conditions
Dr. Phillip C. Stites
Dermatology

The Dermatology Center PLLC

7900 Dallas Street,, 
Fort Smith, AR 
 (5.8 mi)
479-242-6647
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Phillip Stites is a Dermatologist in Fort Smith, Arkansas. Dr. Stites is highly rated in 26 conditions, according to our data. His top areas of expertise are Seborrheic Keratosis, Warts, Actinic Keratosis, and Sunburn. Dr. Stites is currently accepting new patients.

Expertise in
13
conditions
Dr. Mark F. Naylor
Dermatology
Expertise in
13
conditions
Dr. Mark F. Naylor
Dermatology

Advanced Dermatology And Skin Cancer Center, LLC

1444 E Stearns St, Suite 11, 
Fayetteville, AR 
 (60.2 mi)
479-718-7546
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Mark Naylor is a Dermatologist in Fayetteville, Arkansas. Dr. Naylor is highly rated in 13 conditions, according to our data. His top areas of expertise are Pompholyx Eczema, Basal Cell Skin Cancer, GAPO Syndrome, and Atopic Dermatitis. Dr. Naylor is currently accepting new patients.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Looking for the best doctor for you?
Start Here
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile